Robert Califf Nominated To Retake FDA Commissioner Role
Clinical Trial Reform, Staff 'Brain Drain' Among Familiar Challenges Awaiting Cardiologist
Executive Summary
President Biden’s pick for FDA commissioner should remember many of the hot-button issues that he would face if confirmed to a second stint as the nation's top medtech regulator.
You may also be interested in...
Experts: GOP Rift Could Derail Califf Nomination, Time Is Key
While former FDA commissioner Califf was likely picked to head the agency again because he’s already been vetted, some Republicans may use his nomination as a political opportunity to deny Biden a win.
What Might Have Been: US FDA Acting Commissioner Woodcock Testifies In Senate
Acting FDA commissioner Janet Woodcock’s latest appearance before Senate Health Committee shows once again she could easily win enough votes for Senate confirmation in the job – and why she most likely won’t get the chance.
Former US FDA Commish Califf Endorses ‘Tortoise’ Approach To Clinical Trials
The once and likely future FDA commissioner emphasized the value of randomized controlled trials, the fact that not all trials are good for people, and how decentralization and digitization are leaving people behind during a panel discussion.